Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms.
Chaozhuang ShenHongyi YangWenxin ShaoLiang ZhengWei ZhangHaitang XieXuehua JiangLing WangPublished in: Pharmaceutical research (2024)
In clinical practice, the impact of genotyping on the in vivo disposition process of VEN should be considered to ensure the safety and efficacy of treatment.